Upgrade to SI Premium - Free Trial

Amphastar Pharmaceuticals (AMPH) PT Lowered to $19 at Jefferies Following Strong 2Q

August 11, 2017 8:22 AM
Jefferies lowered its price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $19.00 (from $20.00) while maintaining a Buy rating following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles